Clinical Safety, Pharmacokinetics and Early Evidence of Activity of The Oral IAPs Inhibitor Debio 1143 in Combination with Carboplatin and Paclitaxel: a Phase1 Stud

Presented at EORTC 2015, Boston, MA, USA

I. Ray-Coquard (1), C. Le Tourneau (2), N. Isambert (3), C.A. Gomez-Roca (4), P. Cassier (1), M.P. Sablin (2), D. Purcea (5), E. Rouits (5), C. Schusterbauer (5), G. Vuagniaux (5), C. Zanna (5), P. Fumoleau (3), J.P. Delord (4)

(1) Centre Léon Bérard, Lyon, France;
(2) InstitutCurie, Paris, France;
(3) Centre Georges-Francois Leclerc, Dijon, France;
(4) Centre Claudius Regaud, Toulouse, France;
(5) Debiopharm International SA, Lausanne, Switzerland.